These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 35764486)

  • 1. Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19.
    Neal MD; Lawler PR; Zarychanski R
    Blood Adv; 2022 Aug; 6(16):4710-4714. PubMed ID: 35764486
    [No Abstract]   [Full Text] [Related]  

  • 2. Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.
    Piñana JL; Garcia-Sanz R; Martino R; Garcia-Roa M; Martin-Martin GA; Risco-Gálvez I; Tormo M; Martinez-Barranco P; Marcos-Corrales S; Calabuig M; Conesa V; Teruel A; Ruiz-Pérez S; Solano C; Navarro D; Cedillo Á; Sureda A
    Blood Adv; 2022 Jan; 6(3):848-853. PubMed ID: 34905620
    [No Abstract]   [Full Text] [Related]  

  • 3. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
    Piñana JL; Vázquez L; Martino R; de la Cámara R; Sureda A; Rodríguez-Veiga R; Garrido A; Sierra J; Ribera JM; Torrent A; Mateos MV; de la Rubia J; Tormo M; Díez-Campelo M; García-Gutiérrez V; Álvarez-Larrán A; Sancho JM; MartínGarcía-Sancho A; Yañez L; Pérez Simón JA; Barba P; Abrisqueta P; Álvarez-Twose I; Bonanad S; Lecumberri R; Ruiz-Camps I; Navarro D; Hernández-Rivas JÁ; Cedillo Á; García-Sanz R; Bosch F
    Leuk Lymphoma; 2022 Mar; 63(3):538-550. PubMed ID: 34668835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the diagnostic and treatment strategies of patients with hematological diseases during the COVID-19 pandemic with reference to recommendations from American Society of Hematology and European Hematology Association].
    Mori SI
    Rinsho Ketsueki; 2021; 62(2):101-105. PubMed ID: 33678768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematological Findings and Clinical Severity in Pediatric Patients with COVID-19.
    Sookaromdee P; Wiwanitkit V
    Turk J Haematol; 2021 Dec; 38(4):329-330. PubMed ID: 34555887
    [No Abstract]   [Full Text] [Related]  

  • 6. Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease.
    Iluta S; Pasca S; Dima D; Mester G; Urian L; Bojan A; Zdrenghea M; Trifa A; Balacescu O; Tomuleasa C
    Eur J Hosp Pharm; 2022 Nov; 29(6):e8. PubMed ID: 33541912
    [No Abstract]   [Full Text] [Related]  

  • 7. A review on how to do hematology consults during COVID-19 pandemic.
    Sahu KK; Cerny J
    Blood Rev; 2021 May; 47():100777. PubMed ID: 33199084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP).
    Zama D; Baccelli F; Colombini A; Contino A; Calore E; Petris MG; Meneghello L; Mercolini F; Lo Vecchio A; Montalto S; Meazza C; Barone A; Compagno F; Muggeo P; Soncini E; Brescia L; Giraldi E; Giurici N; Mura RM; Cellini M; Perruccio K; Petroni V; La Spina M; Ziino O; Burnelli R; De Santis R; Mascarin M; Barretta V; Tridello G; Cesaro S
    Ann Hematol; 2022 Aug; 101(8):1843-1851. PubMed ID: 35726104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hematology laboratory's response to the COVID-19 pandemic: A scoping review.
    Bell R; Zini G; d'Onofrio G; Rogers HJ; Lee YS; Frater JL
    Int J Lab Hematol; 2021 Apr; 43(2):148-159. PubMed ID: 33180380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Broockman D; Kalla J; Guerrero A; Budolfson M; Eyal N; Jewell NP; Magalhaes M; Sekhon JS
    Vaccine; 2021 Jan; 39(2):309-316. PubMed ID: 33334616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining an Adult Hematology/Oncology Service at a Tertiary Care Center during the SARS-CoV-2 Pandemic: An Eight-Week-Experience with a Newly Implemented Procedural Plan.
    Hemmati PG; Fischer D; Breywisch F; Wohlfarth S; Kramer M; Paland M; Tometten L; Badakhshi H; Ripberger G; Maschmeyer G
    Oncol Res Treat; 2021; 44(6):354-359. PubMed ID: 33940575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development.
    Nguyen LC; Bakerlee CW; McKelvey TG; Rose SM; Norman AJ; Joseph N; Manheim D; McLaren MR; Jiang S; Barnes CF; Kinniment M; Foster D; Darton TC; Morrison J
    Clin Infect Dis; 2021 Feb; 72(4):710-715. PubMed ID: 32628748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Blood Smear Findings in COVID-19.
    Ahnach M; Ousti F; Nejjari S; Houssaini MS; Dini N
    Turk J Haematol; 2020 Nov; 37(4):310-302. PubMed ID: 32586086
    [No Abstract]   [Full Text] [Related]  

  • 14. A pediatric COVID hematology/oncology ward to guarantee adequate medical and nursing assistance.
    Amicucci M; Perigli F; D'Elpidio G; Ripà A; Mastronuzzi A; De Ioris MA; Schiopu AC; Dall'Oglio I; Ciaralli I
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29113. PubMed ID: 34060721
    [No Abstract]   [Full Text] [Related]  

  • 15. Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy.
    Ferrari A; Zecca M; Rizzari C; Porta F; Provenzi M; Marinoni M; Schumacher RF; Luksch R; Terenziani M; Casanova M; Spreafico F; Chiaravalli S; Compagno F; Bruni F; Piccolo C; Bettini L; D'Angiò M; Ferrari GM; Biondi A; Massimino M; Balduzzi A
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28410. PubMed ID: 32452123
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to "CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report" Analysis of six hematological centers in Lombardy : On behalf of CLL commission of Lombardy Hematology Network (REL).
    Reda G; Noto A; Cassin R; Zamprogna G; Borella C; Scarfò L; Farina L; Molteni A; Ghia P; Tedeschi A; Montillo M;
    Leukemia; 2020 Sep; 34(9):2531-2532. PubMed ID: 32753689
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
    Lim HX; Arip M; Yahaya AAA; Jazayeri SD; Poppema S; Poh CL
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1286-1304. PubMed ID: 34856768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Haematologist's Guide to Coronavirus Disease 2019: Encyclopaedia or Doorstop?
    Gale RP
    Acta Haematol; 2021; 144(1):8-9. PubMed ID: 33032279
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hematology in the time of COVID-19].
    Gavillet M; Rufer N; Grandoni F; Carr Klappert J; Zermatten MG; Cairoli A; Canellini G; Alberio L; Duchosal MA; Spertini O; Blum S
    Rev Med Suisse; 2020 Apr; 16(N° 691-2):823-826. PubMed ID: 32348044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
    Manoharan L; Olliaro P; Horby PW; Watson CH
    Trials; 2021 May; 22(1):370. PubMed ID: 34051840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.